Skip to Navigation Skip to UConn Search Skip to Content

COVID-19: Vaccine Program | Testing | Visitor Guidelines | Information for Employees

UConn University of Connecticut school of Health
Search University of Connecticut Search UConn Health
Site A-Z
UConn A-Z

Pharmacy

Search this Site

Pharmacy

MENUMENU
  • Home
  • About Us
    • Mission and Vision
    • History and Timeline
  • Services
    • Services Overview
    • Anticoagulation Clinic
    • Specialty Pharmacy
  • Residency
  • Policies and Procedures
  • Staff References
    • Nursing Hot List
      • Do Not Crush Info
      • Insulin and Hypoglycemia
      • IV Med Guide and Alaris
      • Miscellaneous
      • Controlled Substance Waste
      • Pain Resources
    • Pharmacy Hot List
      • Drug Info Resources
      • Factor Products
      • Falls and Delirium
      • Forms
      • HAART Treatment
      • PCA Calculator
    • Pharmaceutical Waste
    • Anticoagulation and Heparin
      • Inpatient
        • Alteplase (Stroke Kit)
        • Anticoagulation Guidelines
        • Heparin Infusion
        • Warfarin Collaborative Practice
      • Outpatient
        • Outpatient Anticoagulation Clinic
    • Antimicrobial Stewardship/Vanco
      • ASP Mission & Leadership
      • Antibiogram
      • Antibiotic Lock Guidelines
      • Antimicrobial IV to PO Conversion
      • Procalcitonin
      • Restricted Antimicrobials
      • Aminoglycoside Collaborative Practice
      • Vanco Collaborative Practice
    • Dofetilide (Tikosyn)
    • Epoprostenol and Treprostinil
    • Formulary Information
    • High Alert and LASA
    • Interdepartmental Forms
    • Investigational Drug Services
    • IVIG
    • Medication Handling Safety
    • Medication Safety
    • Medication Shortages
    • NICU
    • Oncology/Chemotherapy
    • Pharmacy IT
  • Patient Education
    • COPD/Asthma
    • General Information
    • FDA Medication Guides
  • Contact Us

Dofetilide (Tikosyn)

Dofetilide Guidelines

  • Dofetilide Guidelines for UConn John Dempsey Hospital

Dofetilide (Tikosyn) Manufacturer’s Website (The FDA no longer requires the REMS program for Dofetilide as of March 9, 2016)

  • Dofetilide HCP Website (Pfizer)

    Dofetilide Patient Education

    • Dofetilide Medication Guide
    • UConn Health Home
    • Contact Us
    • UConn Home
    • Web Disclaimers and Copyright
    • Non-Discrimination
    • Notice of Privacy Practices
    • ©2023 UConn Health
    • Webmaster Login